This program will emphasize the evidence-based strategy for the current treatments of the neurological disorders and cutting edge research in novel therapeutics. It will cover new methodologies and advancement in diagnosis and treatment of patients with Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, headache, neuromuscular disorders, sleep disorders, and others.

This activity will update health care professionals on current practices and new developments in prevention, diagnosis and management of COVID-19 in solid organ transplantation.